Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Biosensors & Bioelectronics|July 17, 2024
Smell cancer by machine learning-assisted peptide/MXene bioelectronic arrayJiawang Hu, Nanlin Hu, Donglei Pan, et al.Oncotargets and Therapy|August 19, 2016
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancerChao Liu, Zhou Huang, Qiusheng Wang, et al.Oncotarget|September 23, 2016
Receptor conversion in metastatic breast cancer: a prognosticator of survivalXiangying Meng, Santai Song, Ze-fei Jiang, et al.Medical Oncology (Northwood, London, England)|January 26, 2011
Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancerTao Wang, Shaohua Zhang, Min Zeng, et al.Zhonghua Yi Xue Za Zhi|April 16, 2014
[Clinical observations of ductal carcinoma in situ and early stage breast cancer with invasive depth less than 1 cm]Chang You, Santai Song, Shikai Wu, et al.Journal of Radiation Research|October 7, 2016
Brain metastasis reirradiation in patients with advanced breast cancerZhou Huang, Bing Sun, Ge Shen, et al.International Journal of Surgical Pathology|December 9, 2025
Successful Treatment With Neoadjuvant Chemo-Immunotherapy for Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Patient Report and Literature ReviewLinlin Qu, Jiting Di, Yan Xiong, et al.Journal of Translational Medicine|November 13, 2025
Glutamine metabolism reprogramming promotes bladder cancer progression via PYCR1: a multi-omics and functional validation studyXinjia Ding, Enkui Zhang, Zhou Huang, et al.Oncotarget|September 24, 2016
Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancerBing Sun, Zhou Huang, Shikai Wu, et al.Scientific Reports|May 21, 2025
Real-world comparison of neoadjuvant chemoimmunotherapy and chemotherapy in muscle-invasive bladder cancerXinjia Ding, Chao Liu, Xiaohui Li, et al.Pageof 8